Ubs Group Ag Cyclerion Therapeutics, Inc. Transaction History

Ubs Group Ag

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.43 - $0.9 $1,704 - $3,568	-3,965 Reduced 21.77%	14,247 $6,000
Q4 2022 Feb 08, 2023	BUY	$0.42 - $18.8 $7,649 - $342,385	18,212 New	18,212 $12,000
Q2 2022 Aug 10, 2022	SELL	$0.47 - $1.29 $1,713 - $4,702	-3,645 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.96 - $1.78 $3,499 - $6,488	3,645 New	3,645 $4,000
Q4 2021 Feb 14, 2022	SELL	$1.56 - $2.99 $5,528 - $10,596	-3,544 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.13 $8,938 - $13,521	3,274 Added 1212.59%	3,544 $11,000
Q2 2021 Aug 13, 2021	SELL	$2.18 - $4.29 $9,618 - $18,927	-4,412 Reduced 94.23%	270 $1,000
Q1 2021 May 12, 2021	SELL	$2.69 - $5.12 $1,977 - $3,763	-735 Reduced 13.57%	4,682 $13,000
Q4 2020 Feb 11, 2021	BUY	$2.25 - $7.12 $11,272 - $35,671	5,010 Added 1230.96%	5,417 $17,000
Q3 2020 Nov 12, 2020	SELL	$3.46 - $8.39 $22,050 - $53,469	-6,373 Reduced 94.0%	407 $2,000
Q2 2020 Jul 31, 2020	SELL	$2.37 - $7.14 $17,495 - $52,707	-7,382 Reduced 52.13%	6,780 $40,000
Q1 2020 May 01, 2020	SELL	$2.46 - $5.84 $34,826 - $82,676	-14,157 Reduced 49.99%	14,162 $38,000
Q4 2019 Feb 14, 2020	SELL	$1.8 - $13.43 $19,134 - $142,760	-10,630 Reduced 27.29%	28,319 $77,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $171,388 - $306,895	21,107 Added 118.3%	38,949 $471,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $171,283 - $407,689	17,842 New	17,842 $205,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $170M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.